ML, F., L, S., G, D., MP, H., L, M., L, F., . . . A, L. (2025). Immunogenicity of SARS-CoV-2 mRNA Vaccine in Breast Cancer Patients Undergoing Active Treatment: A Prospective Observational Study.
Citación estilo ChicagoML, Fernández-Murga, Serrano-García L, D'Auria G, Hernández MP, Martínez-Priego L, Ferrús-Abad L, de Marco G, Domínguez-Márquez MV, y Llombart-Cussac A. Immunogenicity of SARS-CoV-2 MRNA Vaccine in Breast Cancer Patients Undergoing Active Treatment: A Prospective Observational Study. 2025.
Cita MLAML, Fernández-Murga, et al. Immunogenicity of SARS-CoV-2 MRNA Vaccine in Breast Cancer Patients Undergoing Active Treatment: A Prospective Observational Study. 2025.
Precaución: Estas citas no son 100% exactas.